Research Nester released a report titledXerostomia Therapeutics Market: Global Demand Analysis Opportunity Outlook 2029which delivers detailed overview of the global xerostomia therapeutics market in terms of market segmentation by therapy type, application and region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The xerostomia therapeutics market is projected to grow with a moderate CAGR during the forecast period, i.e., 2020-2029 on account of the increase in radiation therapy and chemotherapy.According to the Centers for Disease Control Prevention (CDC), every year about 650,000 cancer patients receive chemotherapy in an outpatient oncology clinic.
Request Sample To Learn More About This Report @https://www.researchnester.com/sample-request-2959
The market is segmented based on product into artificial saliva, salivary stimulants, saliva substitutes, drugs, salivary pens and others, out of which, the salivary stimulants segment is anticipated to grab the largest share by the end of 2021 on account of being available in various forms such as mints, sugar-free chewing gums, sprays and mores. A wide range of substitutes for each product is easily available and accessible to patients, thus is expected to the growth of the segment.
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East Africa, out of which, the xerostomia therapeutics market in the Asia Pacific is projected to grow at the highest CAGR throughout the forecast period. Currently, the market in North America holds the largest share due to increasing prevalence of chronic diseases such as Sjogrens syndrome. Furthermore, the growth can be attributed to the expanding medical and healthcare infrastructure, ease of availability of treatments, and beneficial compensation scenario are some of the important factors which are helping the market to grow in the North American region.
Increase in Radiation therapy and Chemotherapy to Drive the Market Growth
According to a survey, it was estimated that Each year, over 1.1 million individuals are estimated to receive chemotherapy or radiation therapy for cancer.
The increasing prevalence of cancer and increase in radiation therapy and chemotherapy are likely to lead to an increased incidence of xerostomia, which is estimated to predominantly drive the xerostomia therapeutics market. Other factors driving the market growth include increasing usage of prescription medicines, easy availability and cost-effectiveness of medicines, growing geriatric population base and increasing prevalence of diseases, such as Sjogrens syndrome, HIV, diabetes, and Alzheimers disease, among other diseases.
